Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.526
-0.000 (-0.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Century Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -26.48 | -126.57 | -136.67 | -130.93 | -95.82 | -53.58 | Upgrade
|
| Depreciation & Amortization | 12.87 | 13.3 | 13.04 | 8.44 | 3.75 | 1.4 | Upgrade
|
| Other Amortization | - | - | 0.09 | 0.3 | 0.31 | 0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | 11.09 | 4.33 | 16.37 | - | - | 4.72 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.04 | -4.81 | -3.98 | - | - | - | Upgrade
|
| Stock-Based Compensation | 8.2 | 12.69 | 14.62 | 10.67 | 4.73 | 0.88 | Upgrade
|
| Other Operating Activities | 1.22 | 0.2 | -1.2 | 1.63 | 0.83 | 0.35 | Upgrade
|
| Change in Accounts Payable | -0.12 | -1.47 | -2.36 | -4.79 | -1.85 | 2.06 | Upgrade
|
| Change in Unearned Revenue | -113.34 | -6.59 | -2.24 | 117.99 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -2.43 | -1.22 | 13.98 | 10.75 | -0.95 | 2.8 | Upgrade
|
| Operating Cash Flow | -112.02 | -110.14 | -88.35 | 14.05 | -89 | -41.27 | Upgrade
|
| Capital Expenditures | -1.14 | -0.15 | -13.74 | -30.6 | -44.97 | -9.83 | Upgrade
|
| Cash Acquisitions | - | -9.61 | - | - | - | -4.72 | Upgrade
|
| Investment in Securities | 116.91 | 57.24 | 74.87 | 17.48 | -253.37 | -8.21 | Upgrade
|
| Investing Cash Flow | 115.75 | 47.48 | 61.13 | -13.13 | -298.34 | -22.76 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 9.73 | Upgrade
|
| Long-Term Debt Repaid | - | - | -10.24 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -10.24 | - | - | 9.73 | Upgrade
|
| Issuance of Common Stock | - | 74.56 | 0.52 | 27.16 | 277.07 | 38.1 | Upgrade
|
| Other Financing Activities | - | - | - | - | -18.92 | -0.14 | Upgrade
|
| Financing Cash Flow | -0.48 | 74.56 | -9.73 | 27.16 | 417.77 | 47.69 | Upgrade
|
| Net Cash Flow | 3.24 | 11.91 | -36.94 | 28.08 | 30.43 | -16.34 | Upgrade
|
| Free Cash Flow | -113.16 | -110.29 | -102.08 | -16.55 | -133.97 | -51.09 | Upgrade
|
| Free Cash Flow Margin | -99.85% | -1673.84% | -4567.52% | -318.37% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.31 | -1.40 | -1.72 | -0.29 | -4.14 | -6.83 | Upgrade
|
| Cash Interest Paid | - | - | 0.59 | 1.1 | 0.97 | 0.21 | Upgrade
|
| Cash Income Tax Paid | 0.49 | 0.5 | 2.52 | - | 0.01 | - | Upgrade
|
| Levered Free Cash Flow | 10.89 | 49.44 | -71.09 | -79.59 | -96.45 | -30.01 | Upgrade
|
| Unlevered Free Cash Flow | 10.89 | 49.44 | -70.85 | -79 | -95.96 | -29.87 | Upgrade
|
| Change in Working Capital | -115.88 | -9.28 | 9.38 | 123.95 | -2.8 | 4.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.